Regulatory Strategy Amid Generic Competition The timing of these brand name approvals appears strategic, occurring as Health Canada reviews applications from multiple generic drug manufacturers
A study has found that treatment with semaglutide led to reduced triptan usage in women
Last April, British Columbia began restricting the sale of Ozempic to people who live in Canada after a huge surge in individuals outside the country filling prescriptions
The clinical evidence for tirzepatide is well-established
Regarding meningioma, an analysis found that about a third of meningioma tumors express GLP-1 receptors, so receptor agonist drugs may have a more direct effect
MK-0616, an oral macrocyclic peptide PCSK9 inhibitor developed by Merck, demonstrated robust LDL-C reductions of up to 60.9% in Phase 2b trials and is now under NDA review ( The historical record, therefore, offers a clear but frequently ignored lesson